Parkman Healthcare Partners’s TELA Bio TELA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-97,816
| Closed | -$460K | – | 103 |
|
|
2024
Q2 | $460K | Buy |
97,816
+148
| +0.2% | +$696 | 0.06% | 87 |
|
|
2024
Q1 | $554K | Sell |
97,668
-5,707
| -6% | -$32.4K | 0.07% | 97 |
|
|
2023
Q4 | $684K | Sell |
103,375
-63,350
| -38% | -$419K | 0.1% | 83 |
|
|
2023
Q3 | $1.33M | Buy |
166,725
+7,699
| +5% | +$61.6K | 0.24% | 88 |
|
|
2023
Q2 | $1.61M | Buy |
159,026
+21,654
| +16% | +$219K | 0.28% | 83 |
|
|
2023
Q1 | $1.46M | Buy |
137,372
+20,704
| +18% | +$220K | 0.32% | 68 |
|
|
2022
Q4 | $1.34M | Buy |
116,668
+6,388
| +6% | +$73.5K | 0.36% | 67 |
|
|
2022
Q3 | $940K | Buy |
110,280
+1,296
| +1% | +$11K | 0.27% | 72 |
|
|
2022
Q2 | $764K | Buy |
108,984
+480
| +0.4% | +$3.37K | 0.28% | 63 |
|
|
2022
Q1 | $1.26M | Buy |
108,504
+4,222
| +4% | +$49.1K | 0.37% | 60 |
|
|
2021
Q4 | $1.34M | Buy |
104,282
+4,282
| +4% | +$54.8K | 0.29% | 68 |
|
|
2021
Q3 | $1.37M | Hold |
100,000
| – | – | 0.35% | 60 |
|
|
2021
Q2 | $1.61M | Buy |
+100,000
| New | +$1.61M | 0.35% | 66 |
|
|
2020
Q1 | – | Sell |
-25,000
| Closed | -$324K | – | 73 |
|
|
2019
Q4 | $324K | Buy |
+25,000
| New | +$324K | 0.09% | 67 |
|